Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAX antisense RNA 1 (MAX-AS1)
- Target
- MAX-AS1
- Molecular classification
- Other (long non-coding RNA; lncRNA)
01
Overview
MAX antisense RNA 1 (MAX-AS1) is classified as a long non-coding RNA (lncRNA) transcribed from the antisense strand of the MAX gene. There is no evidence in the current biomedical literature to support that MAX-AS1 acts as a canonical therapeutic target such as a receptor, enzyme, transporter, or similar molecule. While the gene is listed in genomic databases, there are no substantial reports describing its biological function, involvement in disease, or utility as a therapeutic target or biomarker[4]. Most research and review sources do not mention MAX-AS1 in the context of drug targeting or disease, and there are no drugs known to interact with this RNA. Its molecular functional class is therefore best described as "Other (long non-coding RNA)", and based on available evidence, it should *not* be considered a therapeutic target at this time.
- Other names
- MAX-AS1MAX Antisense RNA 1
02
Biological functions
Unknown (insufficient information for functional assignment)
03
Disease associations
Unknown
Beyond the preview
Go deeper on MAX antisense RNA 1 (MAX-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAX antisense RNA 1 (MAX-AS1).